| Literature DB >> 33083294 |
Chi Zhang1, Bangming Cao1, Xingmei Huang1, Jian Gu1, Ming Xia2, Xiangjun Yang1, Hongxia Li1.
Abstract
BACKGROUND: The role of serum calcium in coronary artery disease (CAD) patients with or without first incident acute myocardial infarction has not been studied previously. This study aimed to assess the relationship between serum calcium and first incident acute myocardial infarction.Entities:
Keywords: Acute myocardial infarction; Coronary artery disease; Cross-sectional; Serum calcium
Year: 2020 PMID: 33083294 PMCID: PMC7548486 DOI: 10.18502/ijph.v49i7.3581
Source DB: PubMed Journal: Iran J Public Health ISSN: 2251-6085 Impact factor: 1.429
Fig. 1:Flow chart of patient selection
Demographic characteristics
| N | (n=4861) | (n=1609) | (n=3252) | |
| Men (n, %) | 3696(76.03) | 1320(82.04) | 2376(73.06) | <0.001 |
| Age (yr) | 65(15) | 62(19) | 66(14) | <0.001 |
| BMI (Kg/m2) | 24.5(3.8) | 24.6(3.7) | 24.5(3.8) | 0.452 |
| Vital signs | ||||
| SBP (mmHg) | 130(20) | 124(29) | 130(20) | <0.001 |
| DBP (mmHg) | 78(15) | 78(16) | 78(13) | 0.386 |
| HR (bpm) | 72(16) | 76(20) | 70(15) | <0.001 |
| Life sytles(n, %) | ||||
| Smoking | <0.001 | |||
| Never | 2242(46.12) | 544(33.81) | 1698(52.21) | |
| Past smoking | 779(16.03) | 178(11.06) | 601(18.48) | |
| Current smoking | 1840(37.85) | 887(55.13) | 953(29.31) | |
| Alcohol intake (n, %) | <0.001 | |||
| Never | 2863(58.90) | 809(50.28) | 2054(63.16) | |
| Past drinking | 69(1.42) | 14(0.87) | 55(1.69) | |
| Current drinking | 1929(39.68) | 786(48.85) | 1143(35.15) | |
| Past history (n, %) | ||||
| Is-stroke | 327(6073) | 83(5.16) | 244(7.50) | 0.002 |
| He-stroke | 14(0.87) | 15(0.46) | 0.09 | |
| PH | 3211(66.06) | 949(58.98) | 2262(69.56) | <0.001 |
| DM | 1230(25.30) | 385(23.93) | 845(25.98) | 0.121 |
| Blood analysis | ||||
| TC (mmol/L) | 3.9(1.43) | 4.29(1.35) | 3.71(1.39) | <0.001 |
| TG (mmol/L) | 1.31(0.95) | 1.36(0.98) | 1.29(0.93) | <0.001 |
| Lp(a) (mg/L) | 120(227.15) | 123(215.4) | 118(233.9) | 0.232 |
| ApoA (g/L) | 1.24(0.29) | 1.2(0.27) | 1.26(0.31) | <0.001 |
| ApoB (g/L) | 0.82(0.38) | 0.92(0.35) | 0.76(0.36) | <0.001 |
| ApoA1/B | 1.5(0.8) | 1.3(0.6) | 1.6(0.8) | <0.001 |
| HDL-C (mmol/L) | 1.07(0.34) | 1.07(0.33) | 1.07(0.34) | 0.943 |
| LDL-C (mmol/L) | 2.31(1.22) | 2.67(1.15) | 2.1(1.16) | <0.001 |
| Serum albumin (g/L) | 40.6(5) | 40(5.3) | 41(4.7) | <0.001 |
| Creatinine (μmol/L) | 72(22) | 72(21.2) | 72.3(22) | 0.415 |
| Serum sodium (mmol/l) | 142(1.4) | 141.3(3.7) | 142.7(3) | <0.001 |
| Serum potassium (mmol/l) | 3.9(0.43) | 3.9(0.4) | 3.9(0.46) | 0.569 |
| Serum phosphate (mmol/l) | 1.05(0.27) | 1.15(0.28) | 1.1(0.25) | <0.001 |
| Serum calcium (mmol/L) | 2.22(0.2) | 2.18(0.21) | 2.24(0.19) | <0.001 |
| Medications (n, %) | ||||
| Aspirin | 4116(84.67) | 1449(90.06) | 2667(82.01) | <0.001 |
| Clopidogrel | 3346(68.83) | 1448(90) | 1898(58.36) | <0.001 |
| ACEI/ARB | 3683(75.77) | 1078(67) | 2605(80.1) | <0.001 |
| Beta-blockers | 3515(72.31) | 1239(77) | 2276(70) | <0.001 |
| CCB | 922(18.97) | 109(6.77) | 813(25) | <0.001 |
| Nitrates | 1521(31.29) | 269(16.72) | 1252(38.5) | <0.001 |
| Statins | 4331(89.1) | 1453(90.3) | 2878(88.5) | 0.055 |
AMI: acute myocardial infarction, BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure, HR: heart rate, IS-stroke: ischemic stroke, HE-stroke: hemorrhagic stroke, PH: primary hypertension, DM: diabetes mellitus, TC: total cholesterol, TG: Triglycerides, Lp (a): Lipoprotein (a), Apo A: Apolipoprotein A, Apo B: Apolipoprotein B, LDL-C: Low-density lipoprotein cholesterol, HDL-C: High-density lipoprotein cholesterol, ACEI/ARB: Angiotensin converting enzyme inhibitor/angiotensin 2 receptor inhibitor, CCB: Calcium channel blocker. Values are medians (interquartile range) or numbers (percentage).
Categorical variables were compared with χ2 test.
Data with skewed distribution are shown as median (IQR). Mann-Whitney U test was performed
OR of per 0.15 mmol/L lower serum calcium levels for first incident AMI
| OR (95%CI) | P values | OR (95%CI) | P values | OR (95%CI) | ||
|---|---|---|---|---|---|---|
| Model 1 | 1.40 (1.31–1.50) | 1.58 (1.37–1.83) | 1.45 (1.36–1.54) | |||
| Model 2 | 1.50 (1.39–1.61) | 1.57 (1.36–1.81) | 1.50 (1.41–1.60) | |||
| Model 3 | 1.30 (1.20–1.42) | 1.38 (1.17–1.62) | 1.32 (1.22–1.42) | |||
Model 1: Crude
Model 2: adjusted for age and sex
Model 3: adjusted for age, sex, drinking, smoking, primary PH, DM, BMI, IS-stroke, HE-stroke, LDL-C, HDL-C, Lp(a), TG, serum albumin, and phosphate
Fig. 2:On a category scale, crude, partially and fully adjusted OR for first incident AMI among CAD patients, grouped by sex. Q1 (as reference), Q2, Q3, Q4, and Q5 represent increased quintile of serum calcium concentrations. Black dots represent point estimates, and error bars, 95% confidence intervals. P values are for trend test
Fig. 3:On a category scale, crude, partially and fully adjusted OR for first incident AMI among CAD patients, grouped by age. Q1 (as reference), Q2, Q3, Q4, and Q5 represent increased quintile of serum calcium concentrations. Black dots represent point estimates, and error bars, 95% confidence intervals. P values are for trend test
Fig. 4:On a continuous scale, fully adjusted OR of per 1SD (0.15 mmol/L) lower serum calcium concentrations for first incident AMI among CAD patients, grouped by characteristic stratification, dichotomously, trichotomous or medially. Black dots represent point estimates, and error bars, 95% confidence intervals. P values are for the interaction